Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 24K
5: R1 Cover Page Document HTML 48K
7: XML IDEA XML File -- Filing Summary XML 11K
10: XML XBRL Instance -- trup-20240402_htm XML 14K
6: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
3: EX-101.LAB XBRL Labels -- trup-20240402_lab XML 66K
4: EX-101.PRE XBRL Presentations -- trup-20240402_pre XML 35K
2: EX-101.SCH XBRL Schema -- trup-20240402 XSD 10K
8: JSON XBRL Instance as JSON Data -- MetaLinks 12± 18K
9: ZIP XBRL Zipped Folder -- 0001371285-24-000103-xbrl Zip 13K
(Address of principal executive offices, including zip code)
(i855)
i727 - 9079
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading Symbol
Name of each exchange on which registered
iCommon stock, $0.00001 par value per share
iTRUP
iThe
NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b)
On April 2, 2024, Daniel “Dan” Levitan and Dr. Zay Satchu, each a member of the Board of Directors (the “Board”) of Trupanion, Inc. (“Trupanion”), notified Trupanion that they will not stand for re-election at the upcoming Annual Stockholders’
Meeting to be held in June 2024 (“2024 Annual Meeting”). Neither Mr. Levitan’s nor Dr. Satchu’s decision not to stand for re-election was a result of any disagreement with Trupanion or the Board. Each of Mr. Levitan and Dr. Satchu have indicated their intention to continue to serve as a director of Trupanion until the 2024 Annual Meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
